Letters
Chronic heart failure
Benefits of β blockers in chronic obstructive pulmonary disease and heart failure
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3316 (Published 19 May 2014) Cite this as: BMJ 2014;348:g3316
- Ben Creagh-Brown, consultant physician1
- 1Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK
- drbencb{at}gmail.com
Williams and Oakeshott caution against the use of the β blocker bisoprolol for chronic heart failure in patients with severe asthma or chronic obstructive …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.